Page 4,675«..1020..4,6744,6754,6764,677..4,6804,690..»

Coaches raise autism awareness

Posted: Published on January 22nd, 2014

Posted January 22, 2014 Pat Skerrys experiences with his son, Owen, have inspired his autism outreach efforts. (Mitchell Layton/Getty) On Monday night, Pat Skerry was babysitting. Which is to say he actually was parenting, though the difference can be blurred amusingly by the harried existence of a college basketball coach. Anyway, it was closing in on 7 p.m. when Skerrys son, Owen, was working the iPad and in particular a specific app his mother installed to help him understand words and communicate. Owen, nearing his fifth birthday, is autistic. His vocabulary and language skills are limited. His intuition is not. Which was how Owen calculated the time of day and tapped into his sense of routine before tapping into technology to issue a pronouncement to a somewhat preoccupied dad. I want to take a bath, Pat Skerry was informed. Hes an unbelievable wizard on the iPad and some of these electronic gadgets, Skerry, the Towson basketball coach, said in a phone conversation Tuesday morning. Hes a heck of a lot smarter than I am with that stuff. If Skerry cant quite use a touch-screen as adeptly, he can use his position and his platform to advance awareness of the condition … Continue reading

Comments Off on Coaches raise autism awareness

Towson’s Skerry, Marshall’s Herrion team to raise autism awareness

Posted: Published on January 22nd, 2014

Posted January 22, 2014 Pat Skerrys experiences with his son, Owen, have inspired his autism outreach efforts. (Mitchell Layton/Getty) On Monday night, Pat Skerry was babysitting. Which is to say he actually was parenting, though the difference can be blurred amusingly by the harried existence of a college basketball coach. Anyway, it was closing in on 7 p.m. when Skerrys son, Owen, was working the iPad and in particular a specific app his mother installed to help him understand words and communicate. Owen, nearing his fifth birthday, is autistic. His vocabulary and language skills are limited. His intuition is not. Which was how Owen calculated the time of day and tapped into his sense of routine before tapping into technology to issue a pronouncement to a somewhat preoccupied dad. I want to take a bath, Pat Skerry was informed. Hes an unbelievable wizard on the iPad and some of these electronic gadgets, Skerry, the Towson basketball coach, said in a phone conversation Tuesday morning. Hes a heck of a lot smarter than I am with that stuff. If Skerry cant quite use a touch-screen as adeptly, he can use his position and his platform to advance awareness of the condition … Continue reading

Comments Off on Towson’s Skerry, Marshall’s Herrion team to raise autism awareness

Opportunity Analyzer: Acute Ischemic Stroke – Opportunity Analysis and Forecasts to 2017

Posted: Published on January 22nd, 2014

Rockville, MD (PRWEB) January 22, 2014 Opportunity Analyzer: Acute Ischemic Stroke - Opportunity Analysis and Forecasts to 2017 Given the Significant Unmet Needs in this Market, Several Opportunities Remain for Novel Therapies One opportunity includes thrombolytics that can be administered beyond nine hours. Although desmoteplase will have a potential extended therapeutic time window of nine hours, enabling a greater proportion of patients to be eligible for thrombolysis, there is ample opportunity for an effective and safe therapy that can be given after nine hours post-stroke onset. Acute Ischemic Stroke (AIS) patients are still awaiting approval of the first effective neuroprotective therapies, and given the lack of Phase III neuroprotective agents, GlobalData does not expect any neuroprotective agents to launch within the five-year forecast period. With the absence of such a product in the AIS treatment paradigm, an approved first-in-class neuroprotective agent is likely to gain rapid patient uptake. Novel neurorestorative therapies - although much progress has been made in the clinical management of stroke, for example in the form of next-generation thrombolytic agents such as desmoteplase, there are still limited treatment options to restore lost function once neuronal death has already occurred. To order this report: Opportunity Analyzer: Acute Ischemic … Continue reading

Comments Off on Opportunity Analyzer: Acute Ischemic Stroke – Opportunity Analysis and Forecasts to 2017

Sleep Apnea Common Among Spinal Cord Injury Patients: Study

Posted: Published on January 22nd, 2014

Sleep apnea is common among spinal cord injury patients, a small new study suggests. The study of 26 people, published in the Journal of Clinical Sleep Medicine, shows that 77 percent of people who have survived a spinal cord injury have sleep-disordered breathing. And nearly all the people in the study -- 92 percent -- reported poor sleep quality. "The majority of spinal cord injury survivors have symptomatic sleep-disordered breathing and poor sleep that may be missed if not carefully assessed," study researcher Dr. Abdulghani Sankari, a physician scientist at John D. Dingell VA Medical Center and Wayne State University School of Medicine, said in a statement. "Our findings help in identifying the mechanism of sleep-disordered breathing in spinal cord injury and may provide potential targets for new treatment." The study included 15 people with cervical injury and 11 people with thoracic injury, which all led to chronic spinal cord injury. Researchers found that there were experiences of both obstructive sleep apnea and central sleep apnea among the patients, with central sleep apnea being more common among those with the cervical injury. Obstructive sleep apnea is typically more common in the general population, and occurs when the airway is blocked … Continue reading

Posted in Spinal Cord Injury Treatment | Comments Off on Sleep Apnea Common Among Spinal Cord Injury Patients: Study

Metro Cinema at Garneau hosted free showing of French film The Intouchables to help inform about medical science

Posted: Published on January 22nd, 2014

More than 400 Edmontonians dropped in for a free movie and popcorn served with a side of neuroscience at the Garneau Theatre on Thursday, Jan. 16. Its a perfect geek date, said Danica Wolkow, a provincial co-ordinator with Alberta Innovates Health Solutions in charge of organizing Science in the Cinema, an initiative that uses film to get the public engaged in science. Thursdays screening played the popular French film The Intouchables, directed by Oliver Nakache and Eric Toledano, where an aristocrat who became quadriplegic after a paragliding accident finds a renewed sense of life after injury thanks to an unlikely caretaker from the projects. Hosted by Karim Fouad, a professor with the University of Albertas faculty of Rehabilitative Medicine, the film served as an uplifting tale of thriving after a spinal cord injury, as medical science has little to offer yet in the way of rehabilitation. We are still very limited in what we can do for a patient like this, said Fouad, who emphasized that while research is progressing, there is no magic bullet for patients paralyzed by spinal cord injury. The U of A is home to North Americas only free-standing faculty of Rehabilitative Medicine and has received … Continue reading

Posted in Spinal Cord Injury Treatment | Comments Off on Metro Cinema at Garneau hosted free showing of French film The Intouchables to help inform about medical science

New avenue to treat diabetes-related vision problems

Posted: Published on January 22nd, 2014

PUBLIC RELEASE DATE: 21-Jan-2014 Contact: Quinn Eastman qeastma@emory.edu 404-727-7829 Emory Health Sciences Dopamine-restoring drugs already used to treat Parkinson's disease may also be beneficial for the treatment of diabetic retinopathy, a leading cause of blindness in adults, researchers have discovered. The results were published in the Jan. 15 issue of Journal of Neuroscience. Diabetic retinopathy affects more than a quarter of adults with diabetes and threatening the vision of more than 600,000 people in the United States. Doctors had previously thought most of the impairment of vision in diabetic retinopathy came from damage to the blood vessels induced by high blood sugar, but had known that dopamine, a vital neurotransmitter in the brain, was also important in the retina. "There was some evidence already that dopamine levels were reduced in diabetic retinopathy, but what's new here is: we can restore dopamine levels and improve visual function in an animal model of diabetes," says Machelle Pardue, PhD, associate professor of ophthalmology at Emory University School of Medicine and research career scientist at the Atlanta VA Medical Center. The first author of the paper is MD/PhD student Moe Aung. Senior authors are Pardue and P. Michael Iuvone, PhD, professor of ophthalmology and … Continue reading

Posted in Parkinson's Treatment | Comments Off on New avenue to treat diabetes-related vision problems

Sanofi’s Aubagio Wins Final Approval From U.K. Cost Agency NICE

Posted: Published on January 22nd, 2014

Sanofis multiple sclerosis drug Aubagio won final approval from the U.K.s health-cost agency, allowing access to a market in which it will compete with Novartis AGs (NOVN) Gilenya. The National Institute for Health and Care Excellence, or NICE, recommended Aubagio, also known as teriflunomide, as a treatment option for adults with relapsing-remitting multiple sclerosis, the most common form of the disease, it said in a statement today. The decision confirms a preliminary ruling made last month in which NICE recommended the drug after Paris-based Sanofi agreed to a price cut. The drug is the second oral MS treatment to win NICEs backing in the U.K., after Basel, Switzerland-based Novartiss Gilenya was approved in April 2012. Aubagio is the only oral MS drug to demonstrate an ability to slow the progression of disability in two trials, William Sibold, the head of MS at Sanofis (SAN) Genzyme unit, said in a telephone interview. That consistent efficacy is something that resonates very well with the community, Sibold said. Aubagio has blockbuster potential, Sibold said, without providing a specific sales forecast. The drug may reach sales of 647 million euros ($876 million) in 2018, according to the average of eight analyst estimates compiled by … Continue reading

Posted in MS Treatment | Comments Off on Sanofi’s Aubagio Wins Final Approval From U.K. Cost Agency NICE

HRT (Hormone Replacement Therapy) Cream for Menopause Treatment / Menopause Symptoms – Video

Posted: Published on January 22nd, 2014

HRT (Hormone Replacement Therapy) Cream for Menopause Treatment / Menopause Symptoms Dr Maura McGill explains about HRT (Hormone Replacement Therapy) cream. To find out more about Menopause Symptoms / Menopause Treatment visit http://www.fixwomenshe... By: Dr Maura McGill … Continue reading

Posted in Hormone Replacement Therapy | Comments Off on HRT (Hormone Replacement Therapy) Cream for Menopause Treatment / Menopause Symptoms – Video

Sex and Hormone Replacement Therapy by Dr. Howard Liebowitz – Video

Posted: Published on January 22nd, 2014

Sex and Hormone Replacement Therapy by Dr. Howard Liebowitz http://www.liebowitzlongevity.com - Sex and Hormone Replacement Therapy by Dr. Howard Liebowitz and Randy Alvarez on the Wellness Hour. Dr. Liebowitz was tra... By: liebowitzlongevity … Continue reading

Posted in Hormone Replacement Therapy | Comments Off on Sex and Hormone Replacement Therapy by Dr. Howard Liebowitz – Video

HRT cuts risk of repeat knee/hip replacement surgery by 40 percent

Posted: Published on January 22nd, 2014

PUBLIC RELEASE DATE: 22-Jan-2014 Contact: Emma Dickinson edickinson@bmj.com 44-020-738-36529 BMJ-British Medical Journal Hormone replacement therapy (HRT) taken regularly for six months after a knee or hip replacement seems to cut the risk of repeat surgery by around 40%, indicates a large population based study published online in the Annals of the Rheumatic Diseases. National data for England and Wales indicate that more than 2% of procedures typically have to be repeated within three years, primarily because of osteolysis (75% of cases). Osteolysis occurs when particles from the implant seep into the surrounding tissue, prompting an inflammatory response which then destroys the bone around the implant. And joint replacement surgery rates are set to rise substantially as the population ages and the prevalence of obesity increases, say the authors. The research team assessed the likelihood of repeat joint replacement surgery among women who required a first knee or hip replacement between 1986 and 2006. The women's details had been entered into the primary care General Practice Research Database (GPRD), which holds millions of anonymised medical records for patients across the UK. More than 21,000 eligible women who met the criteria had not used HRT, while more than 3500 had done so … Continue reading

Posted in Hormone Replacement Therapy | Comments Off on HRT cuts risk of repeat knee/hip replacement surgery by 40 percent

Page 4,675«..1020..4,6744,6754,6764,677..4,6804,690..»